Results 1 to 10 of about 3,065,291 (226)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 1997
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
L, Balducci +3 more
+7 more sources
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
L, Balducci +3 more
+7 more sources
2023
The prostate is the largest accessory gland of the male reproductive tract. Together with seminal vesicles and bulbourethral glands, the prostate is responsible for the production of an alkaline fluid that forms part of the seminal fluid. The prostates of men over 40 years of age are commonly affected by several pathologies, such as benign prostate ...
Faustino-Rocha, AI, Oliveira, PA
openaire +3 more sources
The prostate is the largest accessory gland of the male reproductive tract. Together with seminal vesicles and bulbourethral glands, the prostate is responsible for the production of an alkaline fluid that forms part of the seminal fluid. The prostates of men over 40 years of age are commonly affected by several pathologies, such as benign prostate ...
Faustino-Rocha, AI, Oliveira, PA
openaire +3 more sources
The Lancet, 2008
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
Prostatitis and prostate cancer: Implications for prostate cancer screening
Urology, 2004Measurement of serum prostate-specific antigen (PSA) levels has become the most important single clinical test in the screening for prostate cancer. The possibility that prostatic inflammation (even in asymptomatic men) may substantially elevate PSA values is an important clinical problem, especially given the vagaries of prostate cancer ...
Jun, Kawakami +2 more
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 2005
Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate ...
S. Bracarda +7 more
openaire +3 more sources
Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate ...
S. Bracarda +7 more
openaire +3 more sources
Disease-a-Month, 1991
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Medical Clinics of North America, 1999
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Endocrinology and Metabolism Clinics of North America, 1994
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
JAAPA
Prostate cancer poses a substantial clinical challenge and accounts for a large proportion of cancer-related deaths worldwide. The therapeutic landscape has undergone a large transformation in the past 5 years, resulting in improved patient outcomes.
Valérie, Fonteyne +4 more
openaire +4 more sources
Prostate cancer poses a substantial clinical challenge and accounts for a large proportion of cancer-related deaths worldwide. The therapeutic landscape has undergone a large transformation in the past 5 years, resulting in improved patient outcomes.
Valérie, Fonteyne +4 more
openaire +4 more sources
Seminars in Oncology Nursing, 1993
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths. New advances in screening and imaging allow earlier diagnosis, and improved surgical techniques have reduced sexual dysfunction and incontinence that often resulted from radical prostatectomy. However, many questions remain.
openaire +2 more sources
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths. New advances in screening and imaging allow earlier diagnosis, and improved surgical techniques have reduced sexual dysfunction and incontinence that often resulted from radical prostatectomy. However, many questions remain.
openaire +2 more sources